Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin.
Jain A, Vispute A, Dange A, Naskar A, Mondal A, Vivekanand B, Sharma B, Varade D, Shukla D, Bhatia G, Chaudhari H, Ram Babu K, Gavali O, Sorate S, Bhanushali S, Kothari V, Khandelwal V, Sharma A, Pawar R, Mayabhate M, Shahavi V, Rajput A, Jaiswal M. Jain A, et al. Among authors: sharma b, sharma a. Diabetes Ther. 2024 Jan;15(1):215-227. doi: 10.1007/s13300-023-01504-3. Epub 2023 Nov 14. Diabetes Ther. 2024. PMID: 37957465 Free PMC article.
Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia.
Chandrakala S, Toshniwal M, Halvawala M, Padwal N, Sidharthan N, Malhotra P, Prashantha B, Ballikar R, Shah S, Apte S, Viswanathan TK, Ramanan V, Sharma A, Pawar D, Pawar R, Shahavi V. Chandrakala S, et al. Among authors: sharma a. Indian J Hematol Blood Transfus. 2023 Jul;39(3):522-523. doi: 10.1007/s12288-023-01635-4. Epub 2023 Feb 27. Indian J Hematol Blood Transfus. 2023. PMID: 37304472 Free PMC article.
Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia.
Chandrakala S, Toshniwal M, Halvawala M, Padwal N, Sidharthan N, Malhotra P, Prashantha B, Ballikar R, Shah S, Apte S, Viswanathan TK, Ramanan V, Sharma A, Pawar D, Pawar R, Shahavi V. Chandrakala S, et al. Among authors: sharma a. Indian J Hematol Blood Transfus. 2023 Jul;39(3):435-441. doi: 10.1007/s12288-022-01602-5. Epub 2022 Nov 15. Indian J Hematol Blood Transfus. 2023. PMID: 37304488 Free PMC article.
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study.
Gupta PK, Maheshwari S, Cherian JJ, Goni V, Sharma AK, Tripathy SK, Talari K, Pandey V, Sancheti PK, Singh S, Bandyopadhyay S, Shetty N, Kamath SU, Prahaldbhai PS, Abraham J, Kannan S, Bhat S, Parshuram S, Shahavi V, Sharma A, Verma NN, Kumar U. Gupta PK, et al. Among authors: sharma a, sharma ak. Am J Sports Med. 2023 Jul;51(9):2254-2266. doi: 10.1177/03635465231180323. Epub 2023 Jun 27. Am J Sports Med. 2023. PMID: 37366164 Clinical Trial.
Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.
Aashish M, Arindam N, Siddiqi SS, Bhosle D, Mallikarjuna VJ, Amol D, Sanket S, Omkar G, Parth P, Dhruvi H, Durga P, Pradeep D, Suresh K, Vaishali P, Mayura C, Indraneel B, Jayashri S, Arif F, Raghavendra SK, Deepak V, Ravindra T, Shaishav B, Vijay G, Khan K, Mahajani VV, Sharma AD, Mayabhate M, Pawar RR, Aiwale AS, Vinayaka S. Aashish M, et al. Among authors: sharma ad. Clin Diabetes Endocrinol. 2024 Feb 10;10(1):3. doi: 10.1186/s40842-023-00161-6. Clin Diabetes Endocrinol. 2024. PMID: 38336931 Free PMC article.
Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB®) versus Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study.
Rana PJ, Deshmukh H, Shah U, Kumar V, Kanungo S, Singhal D, Mahapatra SK, Vakharia I, Jaiswal M, Gondane A, Vaidya P, Shahavi V, Shandilya H, Pawar D, Sharma A. Rana PJ, et al. Among authors: sharma a. Clin Ophthalmol. 2024 Oct 29;18:3071-3081. doi: 10.2147/OPTH.S488866. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39493839 Free PMC article. Clinical Trial.
Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial.
Prabhash K, Deshmukh C, Malhotra H, Sharma A, Jain M, Dhamne N, Nagarakar R, Ganesan P, Mahobia VK, Das CK, Kumar R, Shivanna PS, Avaronnan MP, Chaithanya PK, Chaudhary V, Singh K, Aagre S, Ravishankar B, Mehta D, Shilpa K, Maniar V, Chatterjee K, Majumdar SD, Dana R, Noronha V, Menon N, Sharma A, Pawar R, Shahavi V, Yadav R, Aiwale A. Prabhash K, et al. Among authors: sharma a. JCO Glob Oncol. 2024 Nov;10:e2400059. doi: 10.1200/GO.24.00059. Epub 2024 Nov 14. JCO Glob Oncol. 2024. PMID: 39541562 Clinical Trial.
Efficacy and Safety Comparison of Basic Fibroblast Growth Factor-Related Decapeptide 0.1% Solution (bFGFrP) Plus Oral PUVA Combination Therapy with Oral PUVA Monotherapy in the Treatment of Vitiligo.
Nayak CS, Kura MM, Banerjee G, Patil SP, Deshpande A, Sekar S, Sharma A, Pathak R, Sarma P. Nayak CS, et al. Among authors: sharma a. J Cutan Aesthet Surg. 2023 Jan-Mar;16(1):28-33. doi: 10.4103/JCAS.JCAS_33_21. Epub 2023 Apr 28. J Cutan Aesthet Surg. 2023. PMID: 37383981 Free PMC article.
23,178 results
You have reached the last available page of results. Please see the User Guide for more information.